223 related articles for article (PubMed ID: 11319919)
1. Comparison of five retrovirus vectors containing the human IL-2 receptor gamma chain gene for their ability to restore T and B lymphocytes in the X-linked severe combined immunodeficiency mouse model.
Avilés Mendoza GJ; Seidel NE; Otsu M; Anderson SM; Simon-Stoos K; Herrera A; Hoogstraten-Miller S; Malech HL; Candotti F; Puck JM; Bodine DM
Mol Ther; 2001 Apr; 3(4):565-73. PubMed ID: 11319919
[TBL] [Abstract][Full Text] [Related]
2. Retroviral vector for gene therapy of X-linked severe combined immunodeficiency syndrome.
Qazilbash MH; Walsh CE; Russell SM; Noguchi M; Mann MM; Leonard WJ; Liu JM
J Hematother; 1995 Apr; 4(2):91-8. PubMed ID: 7633846
[TBL] [Abstract][Full Text] [Related]
3. Expression of human glucocerebrosidase in murine macrophages: identification of efficient retroviral vectors.
Freas-Lutz DL; Correll PH; Dougherty SF; Xu L; Pluznik DH; Karlsson S
Exp Hematol; 1994 Aug; 22(9):857-65. PubMed ID: 8062885
[TBL] [Abstract][Full Text] [Related]
4. Female germ line mosaicism as the origin of a unique IL-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency.
Puck JM; Pepper AE; Bédard PM; Laframboise R
J Clin Invest; 1995 Feb; 95(2):895-9. PubMed ID: 7860773
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte development and function in dogs with X-linked severe combined immunodeficiency.
Somberg RL; Robinson JP; Felsburg PJ
J Immunol; 1994 Nov; 153(9):4006-15. PubMed ID: 7930609
[TBL] [Abstract][Full Text] [Related]
6. Bone marrow gene therapy for adenosine deaminase deficiency.
Kaptein LC; Einerhand MP; Braakman E; Valerio D; van Beusechem VW
Immunodeficiency; 1993; 4(1-4):335-45. PubMed ID: 7909479
[TBL] [Abstract][Full Text] [Related]
7. Domestic animal models of severe combined immunodeficiency: canine X-linked severe combined immunodeficiency and severe combined immunodeficiency in horses.
Felsburg PJ; Somberg RL; Perryman LE
Immunodefic Rev; 1992; 3(4):277-303. PubMed ID: 1449787
[TBL] [Abstract][Full Text] [Related]
8. Arrested rearrangement of TCR V beta genes in thymocytes from children with X-linked severe combined immunodeficiency disease.
Sleasman JW; Harville TO; White GB; George JF; Barrett DJ; Goodenow MM
J Immunol; 1994 Jul; 153(1):442-8. PubMed ID: 8207253
[TBL] [Abstract][Full Text] [Related]
9. Missense mutation in exon 7 of the common gamma chain gene causes a moderate form of X-linked combined immunodeficiency.
Schmalstieg FC; Leonard WJ; Noguchi M; Berg M; Rudloff HE; Denney RM; Dave SK; Brooks EG; Goldman AS
J Clin Invest; 1995 Mar; 95(3):1169-73. PubMed ID: 7883965
[TBL] [Abstract][Full Text] [Related]
10. Nonrandom X chromosome inactivation in natural killer cells from obligate carriers of X-linked severe combined immunodeficiency.
Wengler GS; Allen RC; Parolini O; Smith H; Conley ME
J Immunol; 1993 Jan; 150(2):700-4. PubMed ID: 8093460
[TBL] [Abstract][Full Text] [Related]
11. The murine interleukin-2 receptor gamma chain gene: organization, chromosomal localization and expression in the adult thymus.
DiSanto JP; Certain S; Wilson A; MacDonald HR; Avner P; Fischer A; de Saint Basile G
Eur J Immunol; 1994 Dec; 24(12):3014-8. PubMed ID: 7805729
[TBL] [Abstract][Full Text] [Related]
12. Patterns of X chromosome inactivation in haematopoietic cells of female carriers of X linked severe combined immunodeficiency.
Hendriks RW; Kraakman ME; Schuurman RK
Immunodeficiency; 1993; 4(1-4):263-5. PubMed ID: 8167715
[TBL] [Abstract][Full Text] [Related]
13. Impairment of ligand binding and growth signaling of mutant IL-2 receptor gamma-chains in patients with X-linked severe combined immunodeficiency.
Ishii N; Asao H; Kimura Y; Takeshita T; Nakamura M; Tsuchiya S; Konno T; Maeda M; Uchiyama T; Sugamura K
J Immunol; 1994 Aug; 153(3):1310-7. PubMed ID: 8027558
[TBL] [Abstract][Full Text] [Related]
14. Introduction of an activated RAS oncogene into murine bone marrow lymphoid progenitors via retroviral gene transfer results in thymic lymphomas.
Dunbar CE; Crosier PS; Nienhuis AW
Oncogene Res; 1991; 6(1):39-51. PubMed ID: 1705319
[TBL] [Abstract][Full Text] [Related]
15. Gene therapy for X-linked immunodeficiencies.
Kinnon C; O'Reilly MA; Pelham A; Malcolm S; Porter CD; Parkar MH; Collins MK; Leveinsky RJ
Allergol Immunopathol (Madr); 1991; 19(1):32-7. PubMed ID: 1683141
[No Abstract] [Full Text] [Related]
16. Overexpression of PDGF-B in murine hematopoietic cells induces a lethal myeloproliferative syndrome in vivo.
Yan XQ; Brady G; Iscove NN
Oncogene; 1994 Jan; 9(1):163-73. PubMed ID: 8302575
[TBL] [Abstract][Full Text] [Related]
17. Long-term expression of gene introduction into normal human T-lymphocytes by retroviral-mediated gene transfer.
Fauser AA
J Cell Biochem; 1991 Apr; 45(4):353-8. PubMed ID: 2045429
[TBL] [Abstract][Full Text] [Related]
18. The mouse severe combined immune deficiency (scid) mutation is closely linked to the B-cell-specific developmental genes VpreB and lambda 5.
Miller RD; Ozaki JH; Riblet R
Genomics; 1993 Jun; 16(3):740-4. PubMed ID: 8100803
[TBL] [Abstract][Full Text] [Related]
19. Correction of proliferative responses in purine nucleoside phosphorylase (PNP)-deficient T lymphocytes by retroviral-mediated PNP gene transfer and expression.
Nelson DM; Butters KA; Markert ML; Reinsmoen NL; McIvor RS
J Immunol; 1995 Mar; 154(6):3006-14. PubMed ID: 7876563
[TBL] [Abstract][Full Text] [Related]
20. CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cells.
Brault J; Liu T; Liu S; Lawson A; Choi U; Kozhushko N; Bzhilyanskaya V; Pavel-Dinu M; Meis RJ; Eckhaus MA; Burkett SS; Bosticardo M; Kleinstiver BP; Notarangelo LD; Lazzarotto CR; Tsai SQ; Wu X; Dahl GA; Porteus MH; Malech HL; De Ravin SS
Front Immunol; 2022; 13():1067417. PubMed ID: 36685559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
